Literature DB >> 25045872

An antitumor boost to TH9 cells.

Sergio A Quezada1, Karl S Peggs1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25045872     DOI： 10.1038/ni.2945

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  14 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo.

Authors:  M Lohoff; D Ferrick; H W Mittrucker; G S Duncan; S Bischof; M Rollinghoff; T W Mak
Journal:  Immunity       Date:  1997-06       Impact factor: 31.745

3.  Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells.

Authors:  Valérie Staudt; Evita Bothur; Matthias Klein; Karen Lingnau; Sebastian Reuter; Nadine Grebe; Bastian Gerlitzki; Markus Hoffmann; Alexander Ulges; Christian Taube; Nina Dehzad; Marc Becker; Michael Stassen; Andrea Steinborn; Michael Lohoff; Hansjörg Schild; Edgar Schmitt; Tobias Bopp
Journal:  Immunity       Date:  2010-07-30       Impact factor: 31.745

Review 4.  Follicular helper CD4 T cells (TFH).

Authors:  Shane Crotty
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.

Authors:  Anneli Jäger; Valérie Dardalhon; Raymond A Sobel; Estelle Bettelli; Vijay K Kuchroo
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

7.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

8.  Late developmental plasticity in the T helper 17 lineage.

Authors:  Yun Kyung Lee; Henrietta Turner; Craig L Maynard; James R Oliver; Dongquan Chen; Charles O Elson; Casey T Weaver
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

9.  The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells.

Authors:  Frédérique Végran; Hélène Berger; Romain Boidot; Grégoire Mignot; Mélanie Bruchard; Magalie Dosset; Fanny Chalmin; Cédric Rébé; Valentin Dérangère; Bernhard Ryffel; Masashi Kato; Armelle Prévost-Blondel; François Ghiringhelli; Lionel Apetoh
Journal:  Nat Immunol       Date:  2014-06-29       Impact factor: 25.606

10.  Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.

Authors:  Rahul Purwar; Christoph Schlapbach; Sheng Xiao; Hong Soon Kang; Wassim Elyaman; Xiaodong Jiang; Anton M Jetten; Samia J Khoury; Robert C Fuhlbrigge; Vijay K Kuchroo; Rachael A Clark; Thomas S Kupper
Journal:  Nat Med       Date:  2012-07-08       Impact factor: 53.440
View more
  4 in total

1.  Physical attraction of Th9 cells is skin deep.

Authors:  Valerie Dardalhon; Mary Collins; Vijay K Kuchroo
Journal:  Ann Transl Med       Date:  2015-04

Review 2.  TH9 cell differentiation, transcriptional control and function in inflammation, autoimmune diseases and cancer.

Authors:  Yan Li; Qing Yu; Zhengguo Zhang; Jian Wang; Simin Li; Jiangyuan Zhang; Guangwei Liu
Journal:  Oncotarget       Date:  2016-10-25

Review 3.  Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities.

Authors:  Zheng Xiang; Wenwei Tu
Journal:  Front Immunol       Date:  2017-08-28       Impact factor: 7.561

Review 4.  IL-9 and IL-9-producing cells in tumor immunity.

Authors:  Jie Wan; Yinqiu Wu; Xiaoyun Ji; Lan Huang; Wei Cai; Zhaoliang Su; Shengjun Wang; Huaxi Xu
Journal:  Cell Commun Signal       Date:  2020-03-30       Impact factor: 5.712
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.